IP Library › Granted Patent US 11,998,625
Granted Patent B2
US 11,998,625 · App. 17/249,912 · Granted Jun 4, 2024

Oral care compositions

Inventors: Aarti Rege (East Windsor, NJ); Michael Prencipe (West Windsor, NJ)
Assignee: Colgate-Palmolive Company
A61K8/27A61K8/19A61K8/20A61K8/21A61K8/24A61K8/362A61Q11/00A61K2800/28A61K2800/48A61K2800/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,998,625
App. No.
17/249,912
Granted
Jun 4, 2024
Kind
B2
Abstract

An oral care composition comprising high water oral care compositions comprising an orally acceptable carrier, zinc phosphate, a first stannous ion source (i.e., stannous fluoride), and a second stannous ion source (i.e., stannous chloride). Methods and uses for this composition are also described throughout.

Claims (18)

1. A high water oral care composition comprising:

an orally acceptable carrier;

zinc phosphate;

a first stannous ion source comprising stannous fluoride in an amount of from about 0.01% to about 5%, by weight of the oral care composition;

a second stannous ion source in an amount from about 0.01% to about 5%, by weight of the oral care composition; and

an organic acid buffer system comprising a carboxylic acid and one or more conjugate base salts thereof.

2. The composition according to claim 1 , wherein the zinc phosphate is a preformed salt of zinc phosphate.

3. The composition according to claim 1 , wherein the amount of zinc phosphate is present in an amount of from 0.05 to 10% by weight, relative to the weight of the oral care composition.

4. The composition according to claim 1 , wherein the amount of the water is 10% by weight or more, relative to the weight of the oral care composition.

5. The composition according to claim 1 , further comprising one or more humectants selected from sorbitol, glycerol, xylitol and propylene glycol, or combinations thereof.

6. The composition according to claim 1 , further comprising one or more surfactants selected from sodium lauryl sulfate, sodium laureth sulfate, or cocamidopropyl betaine, or combinations thereof.

7. The composition according to claim 1 , further comprising an effective amount of one or more alkali phosphate salts.

8. The composition according to claim 7 , wherein the alkali phosphate salts comprise tetrasodium pyrophosphate or tetrapotassium pyrophosphate.

9. The composition according to claim 1 , further comprising one or more sources of zinc ions in addition to the zinc phosphate.

10. The composition according to claim 1 , wherein the oral care composition is a dentifrice.

11. A method of treatment or prevention of erosive tooth demineralization, gingivitis, plaque, and/or dental caries, the method comprising the application to the oral cavity of a person in need thereof the composition according to claim 1 .

12. A method of (i) reducing or inhibiting formation of dental caries, (ii) reducing, repairing, or inhibiting pre-carious lesions of the enamel, (iii) reducing or inhibiting demineralization and promoting remineralization of the teeth, (iv) reducing hypersensitivity of the teeth, (v) reducing or inhibiting gingivitis, (vi) promoting healing of sores or cuts in the mouth, (vii) reducing levels of acid producing bacteria, (viii) increasing relative levels of arginolytic bacteria, (ix) inhibiting microbial biofilm formation in the oral cavity, (x) raising and/or maintaining plaque pH at levels of at least pH 5.5 following sugar challenge, (xi) reducing plaque accumulation, (xii) treating, relieving, or reducing dry mouth, (xiii) cleaning the teeth and oral cavity (xiv) reducing erosion, (xv) preventing stains and/or whitening teeth, (xvi) immunizing the teeth against cariogenic bacteria; and/or (xvii) promoting systemic health, including cardiovascular health, the method comprising applying the oral care composition according to claim 1 to the oral cavity of an individual in need thereof.

13. The composition according to claim 1 , wherein the acid is citric acid, and the one or more conjugate base salts comprise monosodium citrate, disodium citrate, trisodium citrate, and combinations thereof.

Continuity (6)
Continuation 16992718 · Aug 13, 2020
Continuation 16708646 · Dec 10, 2019
Continuation 16376185 · Apr 5, 2019
Continuation 15674719 · Aug 11, 2017
Provisional Application 62437102 · Dec 21, 2016
Related Publication 20210205189A1 · Jul 8, 2021
Cited By (1)
US 12,582,586